Turnstone Biologics Corp. Common Stock Financial Flexibility Index
Turnstone Biologics Corp. Common Stock financial flexibility index. Turnstone Biologics Corp. Common Stock (TSBX) has a Financial Flexibility Index of -0.68x as of June 2025. Free cash flow of $-4.30 Million (operating CF $-4.30 Million minus capex $0.00) represents -1% of total liabilities ($6.34 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Turnstone Biologics Corp. Common Stock (2021–2024)
Financial flexibility index of Turnstone Biologics Corp. Common Stock from 2021 to 2024. Historical Financial Flexibility Index trend for Turnstone Biologics Corp. Common Stock across 4 annual periods. Check Turnstone Biologics Corp. Common Stock cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Turnstone Biologics Corp. Common Stock Financial Flexibility Index by Year (2021–2024)
Turnstone Biologics Corp. Common Stock financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for Turnstone Biologics Corp. Common Stock. For the full cash flow conversion analysis, see TSBX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.75x | $-67.21 Million | $-67.44 Million | $8.67 Million | ▼ -68.9% |
| 2023 | -4.59x | $-64.90 Million | $-66.15 Million | $14.15 Million | ▼ -1406.6% |
| 2022 | -0.30x | $-65.89 Million | $-71.06 Million | $216.41 Million | ▼ -94.1% |
| 2021 | -0.16x | $-42.22 Million | $-45.63 Million | $269.10 Million | — |